This company has been marked as potentially delisted and may not be actively trading. AVROBIO (AVRO) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock AVROBIO Short Interest DataAVROBIO (AVRO) has a short interest of 139,600 shares, representing 0.35% of the float (the number of shares available for trading by the public). This marks a -23.13% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 269,831 shares to cover all short positions.Current Short Interest139,600 sharesPrevious Short Interest181,600 sharesChange Vs. Previous Month-23.13%Dollar Volume Sold Short$206,608.00Short Interest Ratio0.6 Days to CoverLast Record DateMay 31, 2024Outstanding Shares44,890,000 sharesFloat Size39,430,000 sharesShort Percent of Float0.35%Today's Trading Volume206,800 sharesAverage Trading Volume269,831 sharesToday's Volume Vs. Average77% Short Selling AVROBIO? Sign up to receive the latest short interest report for AVROBIO and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAVRO Short Interest Over TimeAVRO Days to Cover Over TimeAVRO Percentage of Float Shorted Over Time AVROBIO Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/2024139,600 shares $206,608.00 -23.1%0.4%0.6 $1.48 5/15/2024181,600 shares $248,792.00 +11.3%0.5%0.8 $1.37 4/30/2024163,200 shares $194,208.00 +19.0%0.4%0.8 $1.19 4/15/2024137,200 shares $172,872.00 -4.2%0.4%0.5 $1.26 3/31/2024143,200 shares $183,296.00 +14.6%0.4%0.5 $1.28 3/15/2024125,000 shares $162,500.00 +3.1%0.3%0.4 $1.30 2/29/2024121,200 shares $158,772.00 -4.2%0.3%0.4 $1.31 2/15/2024126,500 shares $165,715.00 -30.3%0.3%0.4 $1.31 1/31/2024181,500 shares $228,690.00 -61.8%0.5%0.5 $1.26 1/15/2024474,600 shares $669,186.00 -29.2%1.2%1.8 $1.41 Get the Latest News and Ratings for AVRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AVROBIO and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023670,400 shares $911,744.00 -5.8%1.8%2.4 $1.36 12/15/2023711,700 shares $967,912.00 -22.6%1.9%2.5 $1.36 11/30/2023919,000 shares $1.21 million -4.8%2.4%2.8 $1.32 11/15/2023964,900 shares $1.29 million -58.2%2.5%2.8 $1.34 10/31/20232,310,000 shares $3.67 million +2.7%6.0%6.5 $1.59 10/15/20232,250,000 shares $3.51 million +7.1%5.8%5.6 $1.56 9/30/20232,100,000 shares $3.23 million +21.4%5.4%2.1 $1.54 9/15/20231,730,000 shares $2.70 million -2.3%4.5%1.6 $1.56 8/31/20231,770,000 shares $2.69 million -18.4%4.6%1.5 $1.52 8/15/20232,170,000 shares $3.30 million +6.4%5.6%0.8 $1.52 7/31/20232,040,000 shares $3.16 million -15.0%5.5%0.7 $1.55 7/15/20232,400,000 shares $3.38 million +79.1%6.4%0.8 $1.41 6/30/20231,340,000 shares $1.27 million -10.1%3.6%0.6 $0.95 6/15/20231,490,000 shares $1.65 million +4.9%4.0%0.7 $1.11 5/31/20231,420,000 shares $1.56 million +44.4%3.8%0.7 $1.10 5/15/2023983,300 shares $609,547.67 +0.8%2.6%0.5 $0.62 4/30/2023975,800 shares $974,238.72 -5.3%2.6%0.8 $1.00 4/15/20231,030,000 shares $971,290.00 -6.4%2.8%0.8 $0.94 3/31/20231,100,000 shares $1.10 million +86.5%3.0%0.9 $1.00 3/15/2023589,700 shares $725,331.00 +39.0%1.6%0.5 $1.23 2/28/2023424,200 shares $593,880.00 -43.7%1.1%0.3 $1.40 2/15/2023753,500 shares $1.18 million +504.7%2.0%0.6 $1.56 1/31/2023124,600 shares $113,386.00 -6.0%0.3%0.1 $0.91 1/15/2023132,500 shares $119,250.00 +2.3%0.4%0.4 $0.90 12/30/2022129,500 shares $92,320.55 -37.7%0.4%0.4 $0.71 12/15/2022207,800 shares $164,639.94 -32.0%0.6%0.6 $0.79 11/30/2022305,700 shares $277,850.73 +21.1%0.8%0.9 $0.91 11/15/2022252,500 shares $188,844.75 -17.6%0.7%0.8 $0.75 10/31/2022306,300 shares $208,406.52 +7.1%0.8%1.1 $0.68 10/15/2022286,000 shares $167,281.40 +1.5%0.8%1 $0.58Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos 9/30/2022281,800 shares $181,056.50 -3.0%0.8%1 $0.64 9/15/2022290,500 shares $248,203.20 +13.4%0.8%0.9 $0.85 8/31/2022256,200 shares $243,390.00 -15.3%0.7%0.8 $0.95 8/15/2022302,300 shares $335,553.00 -25.7%0.8%0.8 $1.11 7/31/2022406,700 shares $370,259.68 -10.1%1.1%1 $0.91 7/15/2022452,300 shares $431,946.50 -3.9%1.2%1 $0.96 6/30/2022470,400 shares $432,768.00 -72.2%1.5%1 $0.92 6/15/20221,690,000 shares $1.53 million -7.7%5.2%3.3 $0.91 5/31/20221,830,000 shares $1.78 million +4.0%5.7%4.4 $0.97 5/15/20221,760,000 shares $1.42 million +5.4%5.4%4.3 $0.81 4/30/20221,670,000 shares $1.54 million +18.4%4.5%2.9 $0.92 4/15/20221,410,000 shares $1.61 million +7.6%3.8%2.4 $1.14 3/31/20221,310,000 shares $1.73 million +1.6%3.6%1.8 $1.32 3/15/20221,290,000 shares $1.79 million +6.6%3.5%1.6 $1.39 2/28/20221,210,000 shares $1.75 million +11.0%3.3%1.5 $1.45 2/15/20221,090,000 shares $1.81 million +6.9%3.0%1.2 $1.66 1/31/20221,020,000 shares $1.98 million +8.1%2.8%1.3 $1.94 1/15/2022943,500 shares $1.94 million -41.8%2.6%1.4 $2.06 12/31/20211,620,000 shares $6.24 million -10.0%4.4%2.8 $3.85 12/15/20211,800,000 shares $6.26 million -13.9%4.9%5 $3.48 11/30/20212,090,000 shares $8.03 million +8.9%5.7%5.9 $3.84 11/15/20211,920,000 shares $9.93 million -9.0%5.2%5.7 $5.17 10/29/20212,110,000 shares $11.86 million +6.0%5.6%6.1 $5.62 10/15/20211,990,000 shares $11.54 million -12.7%5.3%5.6 $5.80 9/30/20212,280,000 shares $12.72 million -32.9%6.1%6.2 $5.58 9/15/20213,400,000 shares $20.88 million -6.6%9.1%8.5 $6.14 8/31/20213,640,000 shares $24.24 million +3.7%9.8%9.8 $6.66 8/13/20213,510,000 shares $20.95 million -5.4%9.4%8.7 $5.97 7/30/20213,710,000 shares $27.31 million +3.3%10.1%9.3 $7.36 7/15/20213,590,000 shares $27.25 million +1.4%10.2%8.7 $7.59 6/30/20213,540,000 shares $31.47 million +6.0%10.0%8.2 $8.89 6/15/20213,340,000 shares $33.63 million -7.5%9.5%7.7 $10.07 5/28/20213,610,000 shares $32.45 million -4.2%10.2%7.5 $8.99 5/14/20213,770,000 shares $33.14 million -2.1%N/A6.1 $8.79 4/30/20213,850,000 shares $44.62 million -1.8%N/A5.3 $11.59 4/15/20213,920,000 shares $43.94 million -2.7%N/A5.7 $11.21 3/31/20214,030,000 shares $48.04 million +23.6%N/A5.9 $11.92 3/15/20213,260,000 shares $43.06 million -1.5%N/A5.1 $13.21 2/26/20213,310,000 shares $36.41 million +11.1%N/A5.8 $11.00 2/12/20212,980,000 shares $50.09 million +6.4%N/A5.6 $16.81 1/29/20212,800,000 shares $40.04 million +1.1%N/A7.5 $14.30 1/15/20212,770,000 shares $41.38 million -22.0%N/A8.3 $14.94 12/31/20203,550,000 shares $51.55 million +24.6%N/A11.4 $14.52 12/15/20202,850,000 shares $38.48 million -4.0%N/A9.3 $13.50 11/30/20202,970,000 shares $41.67 million -3.3%N/A10.4 $14.03 11/15/20203,070,000 shares $49.83 million +1.3%10.2%13 $16.23 10/30/20203,030,000 shares $45.24 million -2.6%10.1%17.1 $14.93 10/15/20203,110,000 shares $48.33 million -2.8%10.4%17 $15.54 9/30/20203,200,000 shares $41.66 million +14.3%10.7%16.9 $13.02 9/15/20202,800,000 shares $45.72 million +1.5%9.3%12.9 $16.33This Is The Moment You Betray Trump (Or Prove Them Wrong) (Ad)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to Trump’s economic plan. But now there’s a way to protect your retirement without backing down. This free 2025 Wealth Protection Guide reveals how you can use a legal IRS loophole—nicknamed “Piggy Bank”—to shield your savings.Protect your savings without betraying Trump 8/31/20202,760,000 shares $47.80 million -0.7%9.2%11.7 $17.32 8/14/20202,780,000 shares $46.93 million -3.8%9.3%9.7 $16.88 7/31/20202,890,000 shares $48.99 million +6.6%9.8%8.8 $16.95 7/15/20202,710,000 shares $48.73 million +12.5%9.3%8.1 $17.98 6/30/20202,410,000 shares $42.32 million +23.0%8.3%6.9 $17.56 6/15/20201,960,000 shares $40.28 million +13.3%6.7%5.7 $20.55 5/29/20201,730,000 shares $34.98 million +19.3%5.9%5 $20.22 AVRO Short Interest - Frequently Asked Questions What is AVROBIO's current short interest? Short interest is the volume of AVROBIO shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 139,600 shares of AVRO short. 0.35% of AVROBIO's shares are currently sold short. Learn More on AVROBIO's current short interest. What is a good short interest ratio for AVROBIO? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVRO shares currently have a short interest ratio of 1.0. Learn More on AVROBIO's short interest ratio. What is a good short interest percentage for AVROBIO? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.35% of AVROBIO's floating shares are currently sold short. Is AVROBIO's short interest increasing or decreasing? AVROBIO saw a decrease in short interest during the month of May. As of May 31st, there was short interest totaling 139,600 shares, a decrease of 23.1% from the previous total of 181,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is AVROBIO's float size? AVROBIO currently has issued a total of 44,890,000 shares. Some of AVROBIO's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AVROBIO currently has a public float of 39,430,000 shares. How does AVROBIO's short interest compare to its competitors? 0.35% of AVROBIO's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to AVROBIO: Allogene Therapeutics, Inc. (13.77%), ProKidney Corp. (17.15%), Ocugen, Inc. (23.36%), Solid Biosciences Inc. (11.01%), Tevogen Bio Holdings Inc. (11.98%), Fennec Pharmaceuticals Inc (6.27%), Genfit S.A. (0.14%), enGene Holdings Inc. (0.31%), SOPHiA GENETICS SA (0.08%), Kodiak Sciences Inc. (7.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short AVROBIO stock? Short selling AVRO is an investing strategy that aims to generate trading profit from AVROBIO as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against AVROBIO? A short squeeze for AVROBIO occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AVRO, which in turn drives the price of the stock up even further. How often is AVROBIO's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVRO, twice per month. The most recent reporting period available is May, 31 2024. More Short Interest Resources from MarketBeat Related Companies Allogene Therapeutics Short Squeeze ProKidney Short Squeeze Ocugen Short Squeeze Solid Biosciences Short Squeeze Tevogen Bio Short Squeeze Fennec Pharmaceuticals Short Squeeze Genfit Short Squeeze enGene Short Squeeze SOPHiA GENETICS Short Squeeze Kodiak Sciences Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AVRO) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVROBIO, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AVROBIO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.